Woa_老虎社区_美港股上老虎

2021-04-05

Woa

9 Beaten-Down Stocks That Look Promising<blockquote>9只遭受重创但前景光明的股票</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":349206780,"tweetId":"349206780","gmtCreate":1617612479240,"gmtModify":1634297595245,"author":{"id":3574158219076158,"idStr":"3574158219076158","authorId":3574158219076158,"authorIdStr":"3574158219076158","name":"609b13a","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Woa</body></html>","htmlText":"<html><head></head><body>Woa</body></html>","text":"Woa","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/349206780","repostId":1186754751,"repostType":4,"repost":{"id":"1186754751","kind":"news","pubTimestamp":1617611806,"share":"https://www.laohu8.com/m/news/1186754751?lang=zh_CN&edition=full","pubTime":"2021-04-05 16:36","market":"us","language":"en","title":"9 Beaten-Down Stocks That Look Promising<blockquote>9只遭受重创但前景光明的股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1186754751","media":"Barrons","summary":"The S&P 500 closed at a record on Thursday, soaring above 4000 for the first time. But not every sto","content":"The S&amp;P 500 closed at a record on Thursday, soaring above 4000 for the first time. But not every stock has shared in those gains so far this year.<blockquote>标普500周四收盘创历史新高，首次飙升至4000点以上。但今年迄今为止，并非所有股票都分享了这些涨幅。</blockquote>While the majority of S&amp;P 500 stocks are positive for the year, about one in five have declined in the first quarter of 2021. Some are down for fundamental reasons, while others seem to be suffering from the market’s momentum shift from growth stocks to cyclical and value names.<blockquote>虽然大多数标普500股票今年都是积极的，但大约五分之一的股票在2021年第一季度下跌。一些下跌是出于基本面原因，而另一些则似乎受到市场势头从成长型股票转向周期性和价值型股票的影响。</blockquote>Once the headwind wanes, however, names that have been left behind are likely to catch up as their earnings estimates remain strong. In some cases, analysts have adjusted their expectations higher this year. That presents a good opportunity to snap up shares of fundamentally solid companies at discount prices.<blockquote>然而，一旦逆风减弱，那些被抛在后面的公司可能会迎头赶上，因为它们的盈利预期仍然强劲。在某些情况下，分析师今年上调了预期。这为snap以折扣价上涨基本面稳健公司的股票提供了一个很好的机会。</blockquote>Among the nearly 100 S&amp;P 500 companies whose shares are in negative territory year to date, about half are expected to post 2021 earnings per share that are at least 20% higher than fiscal 2019 earnings. Among those, about 30 are expected to see that strength sustain into 2022, meaning their 2022 earnings are expected to grow at least another 10% from 2021 levels.<blockquote>在今年迄今为止股价处于负值的近100家标普500公司中，约有一半预计2021年每股收益将比2019财年收益高出至少20%。其中，约30家公司预计这种实力将持续到2022年，这意味着他们2022年的盈利预计将比2021年的水平至少再增长10%。</blockquote>To find stocks whose earnings potential may not be reflected in share prices,Barron’stook those 30 names and removed any stocks that traded at more than 30 times 2021 earnings estimates. That left us with nine names.<blockquote>要找到盈利潜力可能无法反映在股价上的股票，巴伦周刊选取了这30个名字，并删除了任何交易价格超过2021年盈利预期30倍的股票。我们只剩下九个名字了。</blockquote>Even better, analysts have raised their 2021 and 2022 earnings estimates for all of the stocks since the end of last year, meaning Wall Street is turning more bullish on them. These discounted names are mostly growth stocks across healthcare, tech, telecommunication, and consumer sectors.<blockquote>更好的是，自去年年底以来，分析师上调了所有股票2021年和2022年的盈利预期，这意味着华尔街对它们变得更加看好。这些打折股票大多是医疗保健、科技、电信和消费行业的成长型股票。</blockquote>Left Behind<blockquote>留下了</blockquote>These fundamentally solid stocks are in negative territory for 2021 but look well-positioned to catch up.<blockquote>这些基本面稳健的股票在2021年处于负值区域，但看起来有能力迎头赶上。</blockquote><img src=\"https://static.tigerbbs.com/354b69e346e0d3878e95ee2a83301ccf\" tg-width=\"939\" tg-height=\"781\" referrerpolicy=\"no-referrer\"><blockquote></blockquote>Chip maker&nbsp;Qualcomm(ticker: QCOM), for example, has seen its stock tumble nearly 10% year to date. Investors appear unimpressed by the company’s first-quarter revenue, which was 62% higher than a year ago but&nbsp;still missed analysts’ expectations. In the longer term, the company–known for chips that power smartphone processors–could&nbsp;benefit from the world’s transition to 5G networksand the Biden administration’s proposed infrastructure spending.<blockquote>例如，芯片制造商高通（股票代码：QCOM）的股价今年迄今已下跌近10%。投资者似乎对该公司第一季度营收不以为然，该营收较去年同期增长62%，但仍未达到分析师预期。从长远来看，该公司以为智能手机处理器提供动力的芯片而闻名，可能会受益于世界向5G网络的过渡以及拜登政府拟议的基础设施支出。</blockquote>Vertex Pharmaceuticals&nbsp;(VTRX) shares are another example where a recent pullback due to negative events may have gone too far. In mid-October, the biotech company canceled the development of a once-promising drug after trial results disappointed. Its stock has plunged 23% since and is down 10% year to date. Despite the flop of that one drug,Barron’s&nbsp;wrote in March that&nbsp;Vertex remains a powerhouse in cystic fibrosis treatment&nbsp;and is developing a promising pipeline beyond that.<blockquote>Vertex Pharmaceuticals(VTRX)股票是另一个例子，近期因负面事件导致的回调可能走得太远了。10月中旬，在试验结果令人失望后，这家生物技术公司取消了一种曾经很有前途的药物的开发。此后，其股价已暴跌23%，今年迄今已下跌10%。尽管那一种药物失败了，巴伦周刊三月份写道，Vertex仍然是囊性纤维化治疗领域的巨头，并且正在开发除此之外的有前途的产品线。</blockquote>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>9 Beaten-Down Stocks That Look Promising<blockquote>9只遭受重创但前景光明的股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n9 Beaten-Down Stocks That Look Promising<blockquote>9只遭受重创但前景光明的股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarrons2021-04-05 16:36\n\n</h4>\n</header>\n<article>\nThe S&amp;P 500 closed at a record on Thursday, soaring above 4000 for the first time. But not every stock has shared in those gains so far this year.<blockquote>标普500周四收盘创历史新高，首次飙升至4000点以上。但今年迄今为止，并非所有股票都分享了这些涨幅。</blockquote>While the majority of S&amp;P 500 stocks are positive for the year, about one in five have declined in the first quarter of 2021. Some are down for fundamental reasons, while others seem to be suffering from the market’s momentum shift from growth stocks to cyclical and value names.<blockquote>虽然大多数标普500股票今年都是积极的，但大约五分之一的股票在2021年第一季度下跌。一些下跌是出于基本面原因，而另一些则似乎受到市场势头从成长型股票转向周期性和价值型股票的影响。</blockquote>Once the headwind wanes, however, names that have been left behind are likely to catch up as their earnings estimates remain strong. In some cases, analysts have adjusted their expectations higher this year. That presents a good opportunity to snap up shares of fundamentally solid companies at discount prices.<blockquote>然而，一旦逆风减弱，那些被抛在后面的公司可能会迎头赶上，因为它们的盈利预期仍然强劲。在某些情况下，分析师今年上调了预期。这为snap以折扣价上涨基本面稳健公司的股票提供了一个很好的机会。</blockquote>Among the nearly 100 S&amp;P 500 companies whose shares are in negative territory year to date, about half are expected to post 2021 earnings per share that are at least 20% higher than fiscal 2019 earnings. Among those, about 30 are expected to see that strength sustain into 2022, meaning their 2022 earnings are expected to grow at least another 10% from 2021 levels.<blockquote>在今年迄今为止股价处于负值的近100家标普500公司中，约有一半预计2021年每股收益将比2019财年收益高出至少20%。其中，约30家公司预计这种实力将持续到2022年，这意味着他们2022年的盈利预计将比2021年的水平至少再增长10%。</blockquote>To find stocks whose earnings potential may not be reflected in share prices,Barron’stook those 30 names and removed any stocks that traded at more than 30 times 2021 earnings estimates. That left us with nine names.<blockquote>要找到盈利潜力可能无法反映在股价上的股票，巴伦周刊选取了这30个名字，并删除了任何交易价格超过2021年盈利预期30倍的股票。我们只剩下九个名字了。</blockquote>Even better, analysts have raised their 2021 and 2022 earnings estimates for all of the stocks since the end of last year, meaning Wall Street is turning more bullish on them. These discounted names are mostly growth stocks across healthcare, tech, telecommunication, and consumer sectors.<blockquote>更好的是，自去年年底以来，分析师上调了所有股票2021年和2022年的盈利预期，这意味着华尔街对它们变得更加看好。这些打折股票大多是医疗保健、科技、电信和消费行业的成长型股票。</blockquote>Left Behind<blockquote>留下了</blockquote>These fundamentally solid stocks are in negative territory for 2021 but look well-positioned to catch up.<blockquote>这些基本面稳健的股票在2021年处于负值区域，但看起来有能力迎头赶上。</blockquote><img src=\"https://static.tigerbbs.com/354b69e346e0d3878e95ee2a83301ccf\" tg-width=\"939\" tg-height=\"781\" referrerpolicy=\"no-referrer\"><blockquote></blockquote>Chip maker&nbsp;Qualcomm(ticker: QCOM), for example, has seen its stock tumble nearly 10% year to date. Investors appear unimpressed by the company’s first-quarter revenue, which was 62% higher than a year ago but&nbsp;still missed analysts’ expectations. In the longer term, the company–known for chips that power smartphone processors–could&nbsp;benefit from the world’s transition to 5G networksand the Biden administration’s proposed infrastructure spending.<blockquote>例如，芯片制造商高通（股票代码：QCOM）的股价今年迄今已下跌近10%。投资者似乎对该公司第一季度营收不以为然，该营收较去年同期增长62%，但仍未达到分析师预期。从长远来看，该公司以为智能手机处理器提供动力的芯片而闻名，可能会受益于世界向5G网络的过渡以及拜登政府拟议的基础设施支出。</blockquote>Vertex Pharmaceuticals&nbsp;(VTRX) shares are another example where a recent pullback due to negative events may have gone too far. In mid-October, the biotech company canceled the development of a once-promising drug after trial results disappointed. Its stock has plunged 23% since and is down 10% year to date. Despite the flop of that one drug,Barron’s&nbsp;wrote in March that&nbsp;Vertex remains a powerhouse in cystic fibrosis treatment&nbsp;and is developing a promising pipeline beyond that.<blockquote>Vertex Pharmaceuticals(VTRX)股票是另一个例子，近期因负面事件导致的回调可能走得太远了。10月中旬，在试验结果令人失望后，这家生物技术公司取消了一种曾经很有前途的药物的开发。此后，其股价已暴跌23%，今年迄今已下跌10%。尽管那一种药物失败了，巴伦周刊三月份写道，Vertex仍然是囊性纤维化治疗领域的巨头，并且正在开发除此之外的有前途的产品线。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.barrons.com/articles/9-beaten-down-stocks-that-look-promising-51617404656?mod=RTA\">Barrons</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LDOS":"Leidos Holdings Inc","ALXN":"亚力兄制药","ARTX":"阿罗特克","QCOM":"高通","GPN":"环汇有限公司","DPZ":"达美乐比萨","DVA":"达维塔保健","CHTR":"特许通讯"},"source_url":"https://www.barrons.com/articles/9-beaten-down-stocks-that-look-promising-51617404656?mod=RTA","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186754751","content_text":"The S&P 500 closed at a record on Thursday, soaring above 4000 for the first time. But not every stock has shared in those gains so far this year.While the majority of S&P 500 stocks are positive for the year, about one in five have declined in the first quarter of 2021. Some are down for fundamental reasons, while others seem to be suffering from the market’s momentum shift from growth stocks to cyclical and value names.Once the headwind wanes, however, names that have been left behind are likely to catch up as their earnings estimates remain strong. In some cases, analysts have adjusted their expectations higher this year. That presents a good opportunity to snap up shares of fundamentally solid companies at discount prices.Among the nearly 100 S&P 500 companies whose shares are in negative territory year to date, about half are expected to post 2021 earnings per share that are at least 20% higher than fiscal 2019 earnings. Among those, about 30 are expected to see that strength sustain into 2022, meaning their 2022 earnings are expected to grow at least another 10% from 2021 levels.To find stocks whose earnings potential may not be reflected in share prices,Barron’stook those 30 names and removed any stocks that traded at more than 30 times 2021 earnings estimates. That left us with nine names.Even better, analysts have raised their 2021 and 2022 earnings estimates for all of the stocks since the end of last year, meaning Wall Street is turning more bullish on them. These discounted names are mostly growth stocks across healthcare, tech, telecommunication, and consumer sectors.Left BehindThese fundamentally solid stocks are in negative territory for 2021 but look well-positioned to catch up.Chip maker Qualcomm(ticker: QCOM), for example, has seen its stock tumble nearly 10% year to date. Investors appear unimpressed by the company’s first-quarter revenue, which was 62% higher than a year ago but still missed analysts’ expectations. In the longer term, the company–known for chips that power smartphone processors–could benefit from the world’s transition to 5G networksand the Biden administration’s proposed infrastructure spending.Vertex Pharmaceuticals (VTRX) shares are another example where a recent pullback due to negative events may have gone too far. In mid-October, the biotech company canceled the development of a once-promising drug after trial results disappointed. Its stock has plunged 23% since and is down 10% year to date. Despite the flop of that one drug,Barron’s wrote in March that Vertex remains a powerhouse in cystic fibrosis treatment and is developing a promising pipeline beyond that.","news_type":1,"symbols_score_info":{"LDOS":0.9,"ARTX":0.9,"GPN":0.9,"CHTR":0.9,"DVA":0.9,"QCOM":0.9,"DPZ":0.9,"BLL":0.9,"ALXN":0.9}},"isVote":1,"tweetType":1,"viewCount":656,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/349206780"}